Cargando…
Successful treatment of recurrent subclinical mastitis in cows caused by enrofloxacin resistant bacteria by means of the sequential intramammary infusion of enrofloxacin HCl-2H(2)O and ceftiofur HCl: a clinical trial
BACKGROUND: Recurrent subclinical mastitis (RScM) due to resistant bacteria has low clinical and bacteriological cure rates, often requiring the culling of cows. The sequential intra-mammary administration of enrofloxacin hydrochloride-dihydrate (enro-C) followed by ceftiofur HCl may be useful for t...
Autores principales: | Alfonseca-Silva, Edgar, Cruz-Villa, Juan Carlos, Gutiérrez, Lilia, Sumano, Hector |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Veterinary Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636650/ https://www.ncbi.nlm.nih.gov/pubmed/34697924 http://dx.doi.org/10.4142/jvs.2021.22.e78 |
Ejemplares similares
-
Treatment of Bovine Leptospirosis with Enrofloxacin HCl 2H(2)O (Enro-C): A Clinical Trial
por: Bautista, Jesús Mendoza, et al.
Publicado: (2022) -
Pharmacokinetics of enrofloxacin HCl-2H(2)O (Enro-C) in dogs and pharmacokinetic/pharmacodynamic Monte Carlo simulations against Leptospira spp.
por: Sumano, Hector, et al.
Publicado: (2018) -
Enrofloxacin hydrochloride dihydrate
por: Miranda-Calderón, Jorge E., et al.
Publicado: (2014) -
A non-inferiority study evaluating a new extended-release preparation of tilmicosin injected subcutaneously vs. ceftiofur administered intramammary, as dry-cow therapy in Holstein Friesian cows
por: Ortega, Esteban, et al.
Publicado: (2020) -
Systemic and mammary gland disposition of enrofloxacin in healthy sheep following intramammary administration
por: López, Cristina, et al.
Publicado: (2015)